Aunulife

Aunulife is a biotechnology company specializing in the research, development, and commercialization of functional probiotics, with a specific focus on "psychobiotics" that target the gut-brain axis. The company identifies and clinically validates specific microbial strains, such as Lactobacillus plantarum PS128 and Lactobacillus rhamnosus PS23, to address neurological and mental health conditions. Their primary therapeutic areas include autism spectrum disorder, Parkinson's disease, depression, and anxiety. Aunulife operates a comprehensive platform that spans from strain screening and clinical validation to large-scale manufacturing and commercialization. Based in Shanghai, the company aims to provide evidence-based microbial solutions to improve mental well-being and neurological health through dietary supplements and medical foods.